ES2066540T3 - Tiadiazinonas y los medicamentos que las contienen, especialmente con actividad inotropa-positiva y vasodilatadora. - Google Patents

Tiadiazinonas y los medicamentos que las contienen, especialmente con actividad inotropa-positiva y vasodilatadora.

Info

Publication number
ES2066540T3
ES2066540T3 ES92117675T ES92117675T ES2066540T3 ES 2066540 T3 ES2066540 T3 ES 2066540T3 ES 92117675 T ES92117675 T ES 92117675T ES 92117675 T ES92117675 T ES 92117675T ES 2066540 T3 ES2066540 T3 ES 2066540T3
Authority
ES
Spain
Prior art keywords
positive
tiadiazinones
inotrop
medicines
contain
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES92117675T
Other languages
English (en)
Inventor
Rochus Dr Jonas
Joachim Dr Leibrock
Hans-Jochen Dr Schliep
Christoph Dr Seyfried
Michael Dr Wolf
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Merck Patent GmbH
Original Assignee
Merck Patent GmbH
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Merck Patent GmbH filed Critical Merck Patent GmbH
Application granted granted Critical
Publication of ES2066540T3 publication Critical patent/ES2066540T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D285/00—Heterocyclic compounds containing rings having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by groups C07D275/00 - C07D283/00
    • C07D285/15—Six-membered rings
    • C07D285/16—Thiadiazines; Hydrogenated thiadiazines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/06—Antiasthmatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/24—Antidepressants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/26—Psychostimulants, e.g. nicotine, cocaine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/04—Inotropic agents, i.e. stimulants of cardiac contraction; Drugs for heart failure
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/08—Vasodilators for multiple indications

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Veterinary Medicine (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Biomedical Technology (AREA)
  • Cardiology (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Pulmonology (AREA)
  • Psychiatry (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Pain & Pain Management (AREA)
  • Hospice & Palliative Care (AREA)
  • Rheumatology (AREA)
  • Nitrogen- Or Sulfur-Containing Heterocyclic Ring Compounds With Rings Of Six Or More Members (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Saccharide Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)

Abstract

TIADIACINONA DE LA FORMULA I DONDE R4 SIGNIFICA CLORALCOXI O FLUORALCOXI. MUESTRAN EFECTOS INOTROPICOS POSITIVOS, ACTUAN DE FORMA ANTIASMATICA, Y SON APROPIADAS PARA LA LUCHA CONTRA ENFERMEDADES CARDIOVASCULARES.
ES92117675T 1991-10-23 1992-10-16 Tiadiazinonas y los medicamentos que las contienen, especialmente con actividad inotropa-positiva y vasodilatadora. Expired - Lifetime ES2066540T3 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE4134893A DE4134893A1 (de) 1991-10-23 1991-10-23 Thiadiazinone

Publications (1)

Publication Number Publication Date
ES2066540T3 true ES2066540T3 (es) 1995-03-01

Family

ID=6443196

Family Applications (1)

Application Number Title Priority Date Filing Date
ES92117675T Expired - Lifetime ES2066540T3 (es) 1991-10-23 1992-10-16 Tiadiazinonas y los medicamentos que las contienen, especialmente con actividad inotropa-positiva y vasodilatadora.

Country Status (16)

Country Link
US (1) US5276027A (es)
EP (1) EP0539806B1 (es)
JP (1) JP3193789B2 (es)
AT (1) ATE116644T1 (es)
AU (1) AU653444B2 (es)
CA (1) CA2081049A1 (es)
CZ (1) CZ281377B6 (es)
DE (2) DE4134893A1 (es)
DK (1) DK0539806T3 (es)
ES (1) ES2066540T3 (es)
HU (1) HU214337B (es)
MX (1) MX9206042A (es)
NO (1) NO303013B1 (es)
PL (1) PL171273B1 (es)
TW (1) TW309518B (es)
ZA (1) ZA928236B (es)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
TW309520B (es) * 1994-04-26 1997-07-01 Mitsubishi Chem Corp
DE19500558A1 (de) * 1995-01-11 1996-07-18 Merck Patent Gmbh 3-Alkoxycarbonyl-thiadiazinone
DE19502699A1 (de) * 1995-01-28 1996-08-01 Merck Patent Gmbh Arylalkyl-thiadiazinone
DE19533975A1 (de) * 1995-09-14 1997-03-20 Merck Patent Gmbh Arylalkyl-diazinone
DE10150517A1 (de) * 2001-10-12 2003-04-17 Merck Patent Gmbh Verwendung von Phosphodiesterase IV-Inhibitoren
CZ2004516A3 (cs) * 2001-10-31 2004-08-18 Merckápatentágmbh Inhibitor fosfodiesterázy typu @Ź jeho kombinace s jinými drogami a jeho použití
US7494990B2 (en) 2004-02-04 2009-02-24 Nycomed Gmbh 2-(piperidin-4-yl)-4,5-dihydro-2H-pyridazin-3-one derivatives as PDE4 inhibitors
CN101602687A (zh) * 2008-06-13 2009-12-16 上海特化医药科技有限公司 6-硝基苯乙酮类化合物、其制备方法及用途

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4495185A (en) * 1981-11-12 1985-01-22 Imperial Chemical Industries, Plc 1,2,4-Triazin-3(2H) ones
AU614965B2 (en) * 1987-06-06 1991-09-19 Merck Patent Gesellschaft Mit Beschrankter Haftung Thiadiazinones
EP0478195B1 (en) * 1990-09-21 1999-05-26 Rohm And Haas Company Dihydropyridazinones and pyridazinones as fungicides

Also Published As

Publication number Publication date
US5276027A (en) 1994-01-04
AU2723192A (en) 1993-04-29
JPH05222017A (ja) 1993-08-31
MX9206042A (es) 1993-04-01
DE59201148D1 (de) 1995-02-16
HUT67938A (en) 1995-05-29
TW309518B (es) 1997-07-01
DK0539806T3 (da) 1995-03-13
ZA928236B (en) 1993-05-06
CZ281377B6 (cs) 1996-09-11
EP0539806A1 (de) 1993-05-05
NO303013B1 (no) 1998-05-18
NO924098D0 (no) 1992-10-22
JP3193789B2 (ja) 2001-07-30
EP0539806B1 (de) 1995-01-04
DE4134893A1 (de) 1993-04-29
CA2081049A1 (en) 1993-04-24
PL296314A2 (en) 1993-05-04
HU9203332D0 (en) 1992-12-28
PL171273B1 (pl) 1997-03-28
NO924098L (no) 1993-04-26
ATE116644T1 (de) 1995-01-15
AU653444B2 (en) 1994-09-29
HU214337B (hu) 1998-03-02
CZ263692A3 (en) 1993-05-12

Similar Documents

Publication Publication Date Title
ES520300A0 (es) Procedimiento para la obtencion de 1,4-dihidropiridinas.
ES2066540T3 (es) Tiadiazinonas y los medicamentos que las contienen, especialmente con actividad inotropa-positiva y vasodilatadora.
KR890011596A (ko) 불면증 치료용 의약품의 제조에 있어서 1,4-이치환-피페리디닐 화합물의 용도
DE69815137D1 (de) Epoxybernsteinsäureamid-derivate
CO4520229A1 (es) Derivados de la oxazolidin-2-ona y procedimiento para su obtencion
MX9203585A (es) Derivados de fenotiazina y composiciones farmaceuticas que los contienen.
UY24009A1 (es) Compuestos ariltio útiles como agentes antivirales y antibacteriales
FI810145L (fi) Nya substituerade 1,8-dihydroxi-9-(10h)antracenoner foerfarande foer deras framstaellning och dessa foereningar innehaollande laekemedel
ATE115858T1 (de) Behandlung von schlaf-apnoea mit azapironderivaten.
ES2135384T3 (es) Derivados de 1,4-dihidropiridina opticamente activos y procedimientos para producirlos.
FI841992A0 (fi) Substituerade isokinolinderivat.
DE69029069D1 (de) Verwendung von Xanthinderivaten gegen Magengeschwüre
DE68902874T2 (de) Benzamidine, verwendbar als uv-licht-absorptionsmittel.
IT8420712A1 (it) "Trattamento delle infezioni erpetiche"
TH892EX (th) อนุพันธ์ไทรฟลูออโรมีเธนซัลโฟนานิลีดและการใช้ประโยชน์
TH9148A (th) สารกำจัดเชื้อราประเภทอิมิดาโซล
TH2445A (th) ไพริมิดีนที่ถูกแทนที่
ATE80400T1 (de) Tetrapeptid-hemmstoff zum eintritt in den kreislauf von hemopoietischen stammzellen, verfahren zu deren herstellung und deren anwendungen.
GT198275270A (es) Sales cristalinas de dioxido de benzotiazina.

Legal Events

Date Code Title Description
FG2A Definitive protection

Ref document number: 539806

Country of ref document: ES